{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T06:18:54Z","timestamp":1768285134218,"version":"3.49.0"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,1,1]]},"DOI":"10.1177\/1090820x13515270","type":"journal-article","created":{"date-parts":[[2013,12,13]],"date-time":"2013-12-13T04:01:47Z","timestamp":1386907307000},"page":"118-132","source":"Crossref","is-referenced-by-count":22,"title":["Semipermanent Filler Treatment of HIV-Positive Patients With Facial Lipoatrophy"],"prefix":"10.1093","volume":"34","author":[{"given":"Leo","family":"van Rozelaar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan A.","family":"Kadouch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debbie A.","family":"Duyndam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pythia T.","family":"Nieuwkerk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Femke","family":"Lutgendorff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Refaat B.","family":"Karim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2014,1,1]]},"reference":[{"issue":"4","key":"key\n\t\t\t\t20180205022624_bibr1-1090820X13515270","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/00126334-200212010-00006","article-title":"Impact of lipodystrophy on the quality of life of HIV-1\u2013infected patients","volume":"31","author":"Blanch","year":"2002","journal-title":"J Acquir Immune Defic Syndr."},{"issue":"10","key":"key\n\t\t\t\t20180205022624_bibr2-1090820X13515270","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1086\/383573","article-title":"Factors associated with severe impact of lipodystrophy on the quality of life of patients infected with HIV-1","volume":"38","author":"Blanch","year":"2004","journal-title":"Clin Infect Dis."},{"issue":"11","key":"key\n\t\t\t\t20180205022624_bibr3-1090820X13515270","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/00002030-200107270-00008","article-title":"Clinical assessment of HIV-associated lipodystrophy in an ambulatory population","volume":"15","author":"Lichtenstein","year":"2001","journal-title":"AIDS"},{"issue":"6","key":"key\n\t\t\t\t20180205022624_bibr4-1090820X13515270","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1310\/hct0906-407","article-title":"Improvements in subcutaneous fat, lipid profile, and parameters of mitochondrial toxicity in patients with peripheral lipoatrophy when stavudine is switched to tenofovir (LIPOTEST study)","volume":"9","author":"Ribera","year":"2008","journal-title":"HIV Clin Trials"},{"issue":"18","key":"key\n\t\t\t\t20180205022624_bibr5-1090820X13515270","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1097\/00002030-200112070-00012","article-title":"Failure to maintain long-term adherence to highly active antiretroviral therapy: the role of lipodystrophy","volume":"15","author":"Duran","year":"2001","journal-title":"AIDS"},{"issue":"8","key":"key\n\t\t\t\t20180205022624_bibr6-1090820X13515270","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1468-1293.2008.00606.x","article-title":"Recovery of fat following a switch to nucleoside reverse transcriptase inhibitor-sparing therapy in patients with lipoatrophy: results from the 96-week randomized ANRS 108 NoNuke Trial","volume":"9","author":"Valantin","year":"2008","journal-title":"HIV Med."},{"issue":"11","key":"key\n\t\t\t\t20180205022624_bibr7-1090820X13515270","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1097\/QAD.0b013e32833ac7a2","article-title":"Regional adipose tissue measured by MRI over 5 years in HIV-infected and control participants indicates persistence of HIV-associated lipoatrophy","volume":"24","author":"Grunfeld","year":"2010","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180205022624_bibr8-1090820X13515270","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/1471-2334-10-183","article-title":"The efficacy and safety of insulin-sensitizing drugs in HIV-associated lipodystrophy syndrome: a meta-analysis of randomized trials","volume":"10","author":"Sheth","year":"2010","journal-title":"BMC Infect Dis."},{"issue":"8","key":"key\n\t\t\t\t20180205022624_bibr9-1090820X13515270","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1468-1293.2009.00817.x","article-title":"No significant effect of uridine or pravastatin treatment for HIV lipoatrophy in men who have ceased thymidine analogue nucleoside reverse transcriptase inhibitor therapy: a randomized trial","volume":"11","author":"Calmy","year":"2010","journal-title":"HIV Med."},{"issue":"7","key":"key\n\t\t\t\t20180205022624_bibr10-1090820X13515270","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1097\/01.aids.0000222072.37749.5a","article-title":"Effect of pravastatin on body composition and markers of cardiovascular disease in HIV-infected men\u2014a randomized, placebo-controlled study","volume":"20","author":"Mallon","year":"2006","journal-title":"AIDS"},{"issue":"6","key":"key\n\t\t\t\t20180205022624_bibr11-1090820X13515270","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s00266-008-9189-8","article-title":"Long-term effect of polyalkylimide gel injections on severity of facial lipoatrophy and quality of life of HIV-positive patients","volume":"32","author":"Karim","year":"2008","journal-title":"Aesthetic Plast Surg."},{"key":"key\n\t\t\t\t20180205022624_bibr12-1090820X13515270","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1468-1293.2004.00190.x","article-title":"A randomized open-label study of immediate versus delayed polylactic acid injections for the cosmetic management of facial lipoatrophy in persons with HIV infection","volume":"5","author":"Moyle","year":"2004","journal-title":"HIV Med."},{"key":"key\n\t\t\t\t20180205022624_bibr13-1090820X13515270","first-page":"2274","article-title":"Behandeling van lipoatrofie in het gelaat met L-polymelkzuur: de PLA-studie","volume":"146","author":"Hillebrand","year":"2002","journal-title":"Ned Tijdschr Geneeskd"},{"key":"key\n\t\t\t\t20180205022624_bibr14-1090820X13515270","doi-asserted-by":"crossref","first-page":"55S","DOI":"10.1097\/01.prs.0000234612.20611.5a","article-title":"Injectable poly-L-lactic acid (Sculptra): technical considerations in soft-tissue contouring","volume":"118","author":"Lam","year":"2006","journal-title":"Plast Reconstr Surg."},{"issue":"11","key":"key\n\t\t\t\t20180205022624_bibr15-1090820X13515270","first-page":"1486","article-title":"Evaluation of injectable calcium hydroxylapatite for the treatment of facial lipoatrophy associated with human immunodeficiency virus","volume":"34","author":"Carruthers","year":"2008","journal-title":"Dermatol Surg."},{"issue":"9","key":"key\n\t\t\t\t20180205022624_bibr16-1090820X13515270","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1089\/apc.2008.0230","article-title":"A systematic review of permanent and semipermanent dermal fillers for HIV-associated facial lipoatrophy","volume":"23","author":"Sturm","year":"2009","journal-title":"AIDS Patient Care STDs"},{"issue":"11","key":"key\n\t\t\t\t20180205022624_bibr17-1090820X13515270","first-page":"979","article-title":"HIV-associated facial lipoatrophy","volume":"28","author":"James","year":"2002","journal-title":"Dermatol Surg."},{"issue":"9","key":"key\n\t\t\t\t20180205022624_bibr18-1090820X13515270","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1177\/0956462412474539","article-title":"Current treatment methods for combination antiretroviral therapy-induced lipoatrophy of the face","volume":"24","author":"Kadouch","year":"2013","journal-title":"Int J STD AIDS"},{"key":"key\n\t\t\t\t20180205022624_bibr19-1090820X13515270","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36), I: conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"key\n\t\t\t\t20180205022624_bibr20-1090820X13515270","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1097\/00005650-199108000-00011","article-title":"A health status questionnaire using 30 items from the Medical Outcomes Study: preliminary validation in persons with early HIV infection","volume":"29","author":"Wu","year":"1991","journal-title":"Med Care"},{"key":"key\n\t\t\t\t20180205022624_bibr21-1090820X13515270","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/014662167700100306","article-title":"The CES-D scale: a self-report depression scale for research in the general population","volume":"1","author":"Radloff","year":"1977","journal-title":"Appl Psychol Meas."},{"issue":"17","key":"key\n\t\t\t\t20180205022624_bibr22-1090820X13515270","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1097\/00002030-200311210-00009","article-title":"Polylactic acid implants (New-Fill) to correct facial lipoatrophy in HIV-infected patients: results of the open-label study VEGA","volume":"17","author":"Valantin","year":"2003","journal-title":"AIDS"},{"issue":"3","key":"key\n\t\t\t\t20180205022624_bibr23-1090820X13515270","doi-asserted-by":"crossref","first-page":"34S","DOI":"10.1097\/01.prs.0000234847.36020.52","article-title":"Prospective, open-label, 18-month trial of calcium hydroxylapatite (Radiesse) for facial soft-tissue augmentation in patients with human immunodeficiency virus-associated lipoatrophy: one-year durability","volume":"118","author":"Silvers","year":"2006","journal-title":"Plast Reconstr Surg."},{"key":"key\n\t\t\t\t20180205022624_bibr24-1090820X13515270","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1111\/j.1524-4725.2010.01740.x","article-title":"Use of ultrasound to provide overall information on facial fillers and surrounding tissue","volume":"36","author":"Schelke","year":"2010","journal-title":"Dermatol Surg."},{"issue":"3","key":"key\n\t\t\t\t20180205022624_bibr25-1090820X13515270","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1468-3083.2011.04047.x","article-title":"Ultrasound detection and identification of cosmetic fillers in the skin","volume":"26","author":"Wortsman","year":"2012","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"9","key":"key\n\t\t\t\t20180205022624_bibr26-1090820X13515270","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.crad.2009.05.004","article-title":"Radiological impact of the use of calcium hydroxylapatite dermal fillers","volume":"64","author":"Feeney","year":"2009","journal-title":"Clin Radiol."},{"key":"key\n\t\t\t\t20180205022624_bibr27-1090820X13515270","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1097\/00042728-200806001-00017","article-title":"Radiographic and computed tomographic studies of calcium hydroxylapatite for treatment of HIV-associated facial lipoatrophy and correction of nasolabial folds","volume":"34","author":"Carruthers","year":"2008","journal-title":"Dermatol Surg."}],"container-title":["Aesthetic Surgery Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/asj\/article-pdf\/34\/1\/118\/23787384\/34-1-118.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T13:00:14Z","timestamp":1716296414000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/asj\/article\/34\/1\/118\/2801360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,1]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,1,1]]},"published-print":{"date-parts":[[2014,1,1]]}},"URL":"https:\/\/doi.org\/10.1177\/1090820x13515270","relation":{},"ISSN":["1090-820X","1527-330X"],"issn-type":[{"value":"1090-820X","type":"print"},{"value":"1527-330X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2014,1,1]]},"published":{"date-parts":[[2014,1,1]]}}}